These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 17173138)

  • 1. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation.
    Gao Y; Grassi F; Ryan MR; Terauchi M; Page K; Yang X; Weitzmann MN; Pacifici R
    J Clin Invest; 2007 Jan; 117(1):122-32. PubMed ID: 17173138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-γ directly inhibits TNF-α-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions.
    Kohara H; Kitaura H; Fujimura Y; Yoshimatsu M; Morita Y; Eguchi T; Masuyama R; Yoshida N
    Immunol Lett; 2011 Jun; 137(1-2):53-61. PubMed ID: 21338623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
    Dai SM; Nishioka K; Yudoh K
    Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.
    Takayanagi H; Ogasawara K; Hida S; Chiba T; Murata S; Sato K; Takaoka A; Yokochi T; Oda H; Tanaka K; Nakamura K; Taniguchi T
    Nature; 2000 Nov; 408(6812):600-5. PubMed ID: 11117749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL-independent manner.
    Rifas L; Weitzmann MN
    Arthritis Rheum; 2009 Nov; 60(11):3324-35. PubMed ID: 19877052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen regulation of immune cell bone interactions.
    Weitzmann MN; Pacifici R
    Ann N Y Acad Sci; 2006 Apr; 1068():256-74. PubMed ID: 16831927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of activated T cells on osteoclastogenesis depend on how they are activated.
    Wyzga N; Varghese S; Wikel S; Canalis E; Sylvester FA
    Bone; 2004 Sep; 35(3):614-20. PubMed ID: 15336596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
    van't Hof RJ; Ralston SH
    J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma directly inhibits TRANCE-induced osteoclastogenesis.
    Fox SW; Chambers TJ
    Biochem Biophys Res Commun; 2000 Oct; 276(3):868-72. PubMed ID: 11027561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of T lymphocytes in bone metabolism.
    Weitzmann MN; Pacifici R
    Immunol Rev; 2005 Dec; 208():154-68. PubMed ID: 16313347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-4 inhibits TNF-α-mediated osteoclast formation by inhibition of RANKL expression in TNF-α-activated stromal cells and direct inhibition of TNF-α-activated osteoclast precursors via a T-cell-independent mechanism in vivo.
    Fujii T; Kitaura H; Kimura K; Hakami ZW; Takano-Yamamoto T
    Bone; 2012 Oct; 51(4):771-80. PubMed ID: 22776139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eriodicyol inhibits osteoclast differentiation and ovariectomy-induced bone loss in vivo.
    Lee J; Noh AL; Zheng T; Kang JH; Yim M
    Exp Cell Res; 2015 Dec; 339(2):380-8. PubMed ID: 26450448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal effects of Interferon-γ and IL-4 on differentiation to osteoclast-like cells by RANKL or LPS.
    Hu Y; Ek-Rylander B; Wendel M; Andersson G
    Oral Dis; 2014 Oct; 20(7):682-92. PubMed ID: 24118341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator.
    Cenci S; Toraldo G; Weitzmann MN; Roggia C; Gao Y; Qian WP; Sierra O; Pacifici R
    Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10405-10. PubMed ID: 12923292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos.
    Grcević D; Lukić IK; Kovacić N; Ivcević S; Katavić V; Marusić A
    Clin Exp Immunol; 2006 Oct; 146(1):146-58. PubMed ID: 16968409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen prevents bone loss through transforming growth factor beta signaling in T cells.
    Gao Y; Qian WP; Dark K; Toraldo G; Lin AS; Guldberg RE; Flavell RA; Weitzmann MN; Pacifici R
    Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16618-23. PubMed ID: 15531637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
    Zhu L; Wei H; Wu Y; Yang S; Xiao L; Zhang J; Peng B
    Int J Biochem Cell Biol; 2012 Jul; 44(7):1139-52. PubMed ID: 22521613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo.
    Yonezawa T; Hasegawa S; Asai M; Ninomiya T; Sasaki T; Cha BY; Teruya T; Ozawa H; Yagasaki K; Nagai K; Woo JT
    Eur J Pharmacol; 2011 Jan; 650(2-3):511-8. PubMed ID: 21047508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma production changes in parallel with bacterial lipopolysaccharide induced bone resorption in mice: an immunohistometrical study.
    Moriyama H; Ukai T; Hara Y
    Calcif Tissue Int; 2002 Jul; 71(1):53-8. PubMed ID: 12043012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual modulation of osteoclast differentiation by lipopolysaccharide.
    Zou W; Bar-Shavit Z
    J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.